North America Autoimmune Diagnostics Market By Test Type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - Reactive Protein (CRP), Comprehensive Metabolic Panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) And Others), By Disease - (Localized Auto Immune Disease Diagnostics (Graves’ Disease, Hashimoto's Thyroiditis, Type 1 Diabetes, Multiple Sclerosis, Psoriasis And Others), Systemic Auto Immune Disease Diagnostics(Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis)) By End Users - (Hospitals, Research Centres, Diagnostic Laboratories) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

North America Autoimmune Diagnostics Market By Test Type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - Reactive Protein (CRP), Comprehensive Metabolic Panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) And Others), By Disease - (Localized Auto Immune Disease Diagnostics (Graves’ Disease, Hashimoto's Thyroiditis, Type 1 Diabetes, Multiple Sclerosis, Psoriasis And Others), Systemic Auto Immune Disease Diagnostics(Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis)) By End Users - (Hospitals, Research Centres, Diagnostic Laboratories) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 1191 | Pages: 134 | April 2018 | Region: North America


The North America Autoimmune Diagnostics Market was worth USD 5.88 billion in 2018 and estimated to reach USD 6.95 billion by the end of 2023 with a growing potential of 3.40%. The term “autoimmune disease” refers to a different type of illnesses that involve almost every human organ system. It includes diseases of the nervous, endocrine systems, gastrointestinal and other connective tissues, blood, eyes and blood vessels.

NIH expected that up to 23.5 million Americans have an Auto immune disorders. In comparison, heart diseases up to 22 million and cancer affects up to 9 million people in America. So NIH estimates that the annual direct health spending on auto immune diagnostics is nearly 100 billion (USD).with 50 million Americans living and copying with auto immune disorders more than 75% of them are women. Autoimmune diseases affect women three times more than men. Some of these diseases have even more higher incidence in women. Autoimmune diseases have been mentioned in the top ten leading causes of the deaths among U.S. women aged 65 and younger. So these diseases represent the fourth largest cause of disability among women in the United States.

In North America, the U.S. and Canada have emerged as the most lucrative markets for autoimmune disease diagnostics. So, both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques, and increasing awareness about various medical procedures. The overall high healthcare expenditure across the region, puts North America at the front in the global autoimmune disease diagnostics market

Supportive government policies and Increasing public awareness, increasing occurrence of Auto immune disorders, advancements in health care and improved laboratory techniques are the factors driving the growth of the market. The key restraints that hindering the growth of the auto immune diagnostics market are growing rate of diagnostics errors and low occurrence of localized auto immune disorders as compared to systemic diseases.

The North America Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.

Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves  disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis.

Based on End users into Hospitals, Research centers, and diagnostic laboratories and on the basis of geography, the North America Auto immune Diagnostics market is analysed under various regions namely US, and Canada.

Some of the major companies dominating the North America Auto immune disease market by their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Autoimmune Diagnostics Market By Region, From 2018–2023 (USD Billion)
  2. North America Autoimmune Diagnostics Market By Test Type, From 2018–2023 (USD Billion)
  3. North America Autoantibody Tests Market By Region, From 2018–2023 (USD Billion)
  4. North America Antinuclear Antibody Tests Market By Region, From 2018–2023 (USD Billion)
  5. North America Complete Blood Count (CBC) Market By Region, From 2018–2023 (USD Billion)
  6. North America C - reactive protein (CRP) Market By Region, From 2018–2023 (USD Billion)
  7. North America Comprehensive Metabolic panel Market By Region, From 2018–2023 (USD Billion)
  8. North America Urinalysis Market By Region, From 2018–2023 (USD Billion)
  9. North America Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2018–2023 (USD Billion)
  10. North America Other Test Types Market By Region, From 2018–2023 (USD Billion)
  11. North America Autoimmune Diagnostics Market By Disease Type, From 2018–2023 (USD Billion)
  12. North America Localized Autoimmune Diseases Diagnostics Market By Region, From 2018–2023 (USD Billion)
  13. North America Systemic Autoimmune Diseases Diagnostics Market By Region, From 2018–2023 (USD Billion)
  14. United States Autoimmune Diagnostics Market By Test Type, From 2018–2023 (USD Billion)
  15. United States Autoimmune Diagnostics Market By Disease Type, From 2018–2023 (USD Billion)
  16. Canada Autoimmune Diagnostics Market By Test Type, From 2018–2023 (USD Billion)
  17. Canada Autoimmune Diagnostics Market By Disease Type, From 2018–2023 (USD Billion)
  18. North America Localized Autoimmune Disease Diagnostics Market By Type, From 2018–2023 (USD Billion)
  19. North America Graves' Disease Market By Region, From 2018–2023 (USD Billion)
  20. North America Hashimoto's Thyroiditis Market By Region, From 2018–2023 (USD Billion)
  21. North America Multiple Sclerosis Market By Region, From 2018–2023 (USD Billion)
  22. North America Type 1 diabetes Market By Region, From 2018–2023 (USD Billion)
  23. North America Psoriasis Market By Region, From 2018–2023 (USD Billion)
  24. North America Other Localized Autoimmune Diagnostics Market By Region, From 2018–2023 (USD Billion)
  25. United States Localized Autoimmune Disease Diagnostics Market By Type, From 2018–2023 (USD Billion)
  26. Canada Localized Autoimmune Disease Diagnostics Market By Type, From 2018–2023 (USD Billion)
  27. North America Systemic Auto-immune disease diagnostics Market By Type, From 2018–2023 (USD Billion)
  28. North America Rheumatoid Arthritis (RA) Market By Region, From 2018–2023 (USD Billion)
  29. North America Ankylosing Spondylitis Market By Region, From 2018–2023 (USD Billion)
  30. North America Systemic Lupus Erythematosus (SLE) Market By Region, From 2018–2023 (USD Billion)
  31. United States Systemic Auto-immune disease diagnostics Market By Type, From 2018–2023 (USD Billion)
  32. Canada Systemic Auto-immune disease diagnostics Market By Type, From 2018–2023 (USD Billion)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018 To ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.